Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | TP53 | P04637 | 6/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10550927 | 0.93 | SLC6A9 (0.46) | LMNATP53ENPP2THRBMAPT | |
| SCHEMBL10548481 | 0.90 | MAPT (0.39) | LMNATP53MAPT | |
| SCHEMBL10551752 | 0.89 | SLC6A9 (0.39) | LMNATP53ENPP2MAPTSLC6A9 | |
| SCHEMBL10549336 | 0.87 | SLC6A9 (0.39) | LMNATP53ENPP2TDP1MAPT | |
| SCHEMBL10548020 | 0.87 | SLC6A9 (0.53) | LMNATP53ENPP2MAPTSLC6A9 | |
| SCHEMBL10382807 | 0.86 | SLC6A9 (0.41) | LMNATP53SLC6A9 | |
| SCHEMBL9537203 | 0.85 | TP53 (0.47) | LMNATP53ENPP2THRBTDP1 | |
| SCHEMBL10547517 | 0.84 | SLC6A2 (0.40) | LMNATDP1 | |
| SCHEMBL10548825 | 0.83 | KCNH2 (0.42) | LMNATP53MAPT | |
| SCHEMBL1152449 | 0.80 | KCNH2 (0.46) | LMNATP53ENPP2THRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4839374-A | TREATING ALLERGIES | JANSSEN PHARMACEUTICA, N.V. (BE) | 1989-06-13 | — | — | US | disclosed |
| US-4695575-A | ANTIHISTAMINES | JANSSEN PHARMACEUTICA, N.V. (BE) | 1987-09-22 | — | — | US | disclosed |
| EP-0151826-A1 | 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines | JANSSEN PHARMACEUTICA N.V. (BE) | 1985-08-21 | — | — | EP | disclosed |